TREA

87888556 - CONSTELLATION PHARMACEUTICALS

Follow

Information

  • Trademark
  • 87888556
  • Serial Number
    87888556
  • Filing Date
    April 23, 2018
    6 years ago
  • Transaction Date
    November 05, 2024
    2 months ago
  • Status Date
    November 05, 2024
    2 months ago
  • Published for Opposition Date
    September 13, 2022
    2 years ago
  • Location Date
    November 08, 2022
    2 years ago
  • Status Code
    733
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SAUNDERS, ANDREA
  • Attorney Docket Number
    124033-90201
    Attorney Name
    KEITH TOMS
    Law Office Assigned Location Code
    M80
  • Owners
Information
Mark Drawing Code
3
Mark Identification
CONSTELLATION PHARMACEUTICALS
Case File Statements
  • DM0000: The mark consists of the stylized words "Constellation" about above the word "Pharmaceuticals" and a stylized design of three tethered balls on the right and connected by bands, with the lowest ball representing the second letter "O" in "Constellation.
  • GS0051: Pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of cancer, inflammatory, and fibrotic disorders; pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceutical preparations for the treatment of lymphomia, solid cancers, blood disease, myelofibrosis, Alzheimer's disease, arthritis, Sjogren's syndrome, autoimmune hepatitis, systemic lupus erythematosus, venus thromboembolism (VTE), cancer associated thrombosis (CAT), renal autoimmune disease, pulmonary sarcoidosis, severe atopic dermatitis, diabetes, asthma, chronic obstructive pulmonary disease (COPD)
  • CC0000: Color is not claimed as a feature of the mark.
  • DS0000: "PHARMACEUTICALS"
  • GS0421: Pharmaceutical research and development; Research and development in the fields of genetics, pharmaceuticals, cancer, epigenetics, and immune-oncology, all of the foregoing for the purposes of drug development; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; pharmaceutical products development
Case File Event Statements
  • 4/26/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/2/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/3/2018 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 8/13/2018 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/13/2018 - 6 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/13/2018 - 6 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/13/2018 - 6 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/13/2019 - 5 years ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/13/2019 - 5 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/13/2019 - 5 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/13/2019 - 5 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/13/2019 - 5 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/13/2019 - 5 years ago
    12 - CORRESPONDENCE E-MAILED Type: GRML
  • 5/31/2019 - 5 years ago
    14 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 5/31/2019 - 5 years ago
    15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/9/2019 - 5 years ago
    16 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/9/2019 - 5 years ago
    17 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/9/2019 - 5 years ago
    18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/9/2020 - 4 years ago
    19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/9/2020 - 4 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/10/2020 - 4 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/31/2020 - 4 years ago
    22 - FINAL REFUSAL WRITTEN Type: CNFR
  • 3/31/2020 - 4 years ago
    24 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 3/31/2020 - 4 years ago
    23 - FINAL REFUSAL E-MAILED Type: GNFR
  • 9/30/2020 - 4 years ago
    25 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 9/30/2020 - 4 years ago
    26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/1/2020 - 4 years ago
    27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/1/2020 - 4 years ago
    28 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 10/2/2020 - 4 years ago
    29 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 10/2/2020 - 4 years ago
    30 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 10/6/2020 - 4 years ago
    31 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 10/6/2020 - 4 years ago
    32 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/6/2020 - 4 years ago
    33 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/7/2021 - 3 years ago
    34 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 5/20/2022 - 2 years ago
    36 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 6/15/2022 - 2 years ago
    37 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 7/5/2022 - 2 years ago
    40 - NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED Type: GEA1
  • 10/12/2021 - 3 years ago
    35 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 7/5/2022 - 2 years ago
    38 - ACTION CONTINUING FINAL - COMPLETED Type: CNCF
  • 7/5/2022 - 2 years ago
    39 - ACTION DENYING REQ FOR RECON E-MAILED Type: GECD
  • 8/1/2022 - 2 years ago
    41 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 8/3/2022 - 2 years ago
    42 - ASSIGNED TO LIE Type: ALIE
  • 8/3/2022 - 2 years ago
    43 - DATA MODIFICATION COMPLETED Type: DMCC
  • 8/10/2022 - 2 years ago
    44 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/10/2022 - 2 years ago
    45 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/10/2022 - 2 years ago
    46 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/10/2022 - 2 years ago
    47 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 8/24/2022 - 2 years ago
    49 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/13/2022 - 2 years ago
    50 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/13/2022 - 2 years ago
    51 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/12/2022 - 2 years ago
    52 - EXPARTE APPEAL TERMINATED Type: EXPT
  • 8/10/2022 - 2 years ago
    48 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/8/2022 - 2 years ago
    53 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/8/2023 - a year ago
    54 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/8/2023 - a year ago
    55 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/8/2023 - a year ago
    56 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/10/2023 - a year ago
    57 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/7/2023 - a year ago
    58 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/7/2023 - a year ago
    59 - SOU EXTENSION 2 FILED Type: EXT2
  • 11/7/2023 - a year ago
    60 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 11/9/2023 - a year ago
    61 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/6/2024 - 8 months ago
    64 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 5/6/2024 - 8 months ago
    63 - SOU EXTENSION 3 FILED Type: EXT3
  • 5/6/2024 - 8 months ago
    62 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/7/2024 - 8 months ago
    65 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/5/2024 - 2 months ago
    66 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 11/5/2024 - 2 months ago
    69 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/5/2024 - 2 months ago
    68 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 11/5/2024 - 2 months ago
    67 - SOU EXTENSION 4 FILED Type: EXT4